AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2026
Feb 20, 2026
35599_dirs_2026-02-19_1cee3745-c5ed-4c9a-a222-c7e728a00242.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2026-02-18
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | Common shares | M | 2450 | $4.08 | Acquired | 215108 | Direct |
| 2026-02-18 | Common shares | M | 27285 | — | Acquired | 242393 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Stock Options | $4.08 | M | 2450 | Disposed | 2031-12-20 | Options (2450) | Direct |
Footnotes
F1: Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031.
F2: Represents settlement of PSUs that vested on February 18, 2026.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20